Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant
Titel:
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant
Auteur:
Nikolousis, E. Robinson, S. Nagra, S. Brookes, C. Kinsella, F. Tauro, S. Jeffries, S. Griffiths, M. Mahendra, P. Cook, M. Paneesha, S. Lovell, R. Kishore, B. Chaganti, S. Malladi, R. Raghavan, M. Moss, P. Milligan, D. Craddock, C.